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SUMMARY 
Background: The ability of the Candida species to colonize surfaces can be considered a risk 
factor for oral infection. 
Aims: The aim of this work was to establish oral Candida carriage in patients attending a dental 
clinic in Braga, Portugal. 
Methods: A total of 97 patients were analysed. Swab samples were collected, and directly 
cultured in CHROMagar Candida. Representative yeasts were identified by polymerase chain 
reaction.  
Results: From the samples analysed 54.6% (n=53) were Candida positive, and Candida albicans 
was the most frequently isolated species, accounting for 79% of all the species identified. Non-C. 
albicans Candida (NCAC) species recovered included Candida parapsilosis, Candida glabrata, 
Candida tropicalis, and Candida guilliermondii. There was a lack of association between the 
presence of C. albicans, and NCAC species, and age, gender or prostheses wearing in this 
population. In 17% of the cases (n=9) polymicrobial cultures, with two different Candida 
species, were identified.  
Conclusions: This study shows a high Candida carriage rate among this population, thus 
pointing to the relevance of an accurate diagnostic approach in Candida species identification. 
 
RESUMEN 
Antecedentes: La capacidad que poseen las diferentes especies de Candida de colonizar las 
superficies, puede ser considerada como un factor de riesgo para la infección oral. 
Objetivos: El objetivo de este estudio fue establecer la colonización oral por Candida en 
pacientes que asisten a una clinica dental en Braga, Portugal. 
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Métodos: Un total de 97 pacientes fueron estudiados. Se colectaron muestras bucales con hisopo 
y fueron cultivadas directamente en CHROMagar Candida. Las levaduras seleccionadas se 
identificaron mediante reacción en cadena de la polimerasa.  
Resultados: De las muestras analizadas 54.6% (n=53) fueron positivas para Candida. Candida 
albicans fue la especie más frecuentemente aislada, representado el 79% de todas las especies 
identificadas. Las especies de Candida no-Candida albicans (CNCA) aisladas fueron C. 
parapsilosis, C. glabrata, C. tropicalis y C. guilliermondii. En la población estudiada no se 
observó asociación entre la presencia de C. albicans y CNCA con la edad, el sexo o el uso de 
prótesis. En el 17% de los casos (n=9) se identificó colonización mixta con dos especies de 
Candida.  
Conclusiones: Este estudio muestra una alta incidencia de colonización por Candida en esta 
población; por lo tanto, se sugiere la necesidad de un diagnóstico preciso para la identificación 
de las especies de Candida. 
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INTRODUCTION 
Colonization of the oral cavity by Candida species was defined as the acquisition, and 
maintenance of yeast cells without clinical signs. This process entails Candida species 
acquisition, growth, and removal [3]. 
Within the yeast oral community Candida albicans is the most frequently found (47–75% of the 
yeasts isolated) [4]. However, other yeast species have been increasingly identified, such as non-
C. albicans Candida (NCAC) species( Candida glabrata, Candida parapsilosis, Candida krusei, 
Candida tropicalis, Candida dubliniensis, and Candida guilliermondii) Saccharomyces 
cerevisiae, Trichosporon species, and Yarrowia lipolytica [2,15,18,29].  
Although the presence of Candida species is not an indication of disease, the ability of the yeasts 
to overcome the host clearance mechanisms and to colonize surfaces can be considered a risk 
factor for oral infection. The balance between Candida colonization, and candidiasis rely on the 
balance between pathogen characteristics (e.g. production of adhesins, secreted aspartyl 
proteinases), and host factors [12]. Host local predisposing conditions comprise: (i) reduced 
saliva secretion, (ii) epithelial changes, and local mucosal diseases, (iii) changes in commensal 
flora, (iv) high carbohydrate diet, and (v) denture wearing. Additionally, host systemic factors 
have also been associated with Candida oral colonization, and include: (i) age, (ii) tobacco 
smoking (iii) endocrine disorders, including diabetes, hypothyroidism, hyperparathyroidism, (iv) 
rheumatic diseases, (v) nutritional deficiencies (iron or folate deficiencies), (vi) 
immunosuppressive conditions, such as chemotherapy, deficiencies of humoral or cell-mediated 
immunity, human immunodeficiency virus infection, and acquired immunodeficiency syndrome, 
and (vii) drugs: broad-spectrum antibiotics, and corticosteroids [1,4,10,18]. 
To the authors’ knowledge oral Candida carriage prevalence, and aetiology studies were not yet 
performed in the Portuguese population. Thus, the main objective of this study was to evaluate 
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oral Candida carriage in patients attending a dental clinic in Braga, Portugal. 
 
PATIENTS AND METHODS 
Candida type strains 
For quality control purposes, the following Candida type strains were used in the identification 
procedures of Candida isolates: C. albicans CECT 1472, C. dubliniensis, strain provided by 
Biognostica from United Kingdom National External Quality Assessment Service, C. glabrata 
ATCC 2001, C. guilliermondii ATCC 6260, C. kefyr ATCC 204093, C. krusei ATCC 6258, C. 
parapsilosis ATCC 22019, and C. tropicalis ATCC 750. These strains were maintained on 
Sabouraud dextrose agar. 
Patients 
Samples were collected from a total of 97 asymptomatic individuals (77 females, and 20 males) 
attending a dental clinic in Braga, Portugal over a 12-month period (May 2005 to 2006). Each of 
the potential subjects was informed of the aims, and methods of the study, and anticipated 
benefits, and potential risks, according to the World Medical Association Declaration of 
Helsinki. Data on patient age, oral hygiene habits, health status, medications, and prosthesis 
wearing were collected.  
Sample collection  
Samples were collected by passing a sterile swab (UNI-TER, MEUS, Padua, Italy) across the 
oral mucosa: tongue, hard palate, and gums, and replaced in its sterile container tube. Samples 
were kept at 4C, and analysed within 24 h. 
Candida species identification 
Medium for the primary isolation 
CHROMagar™ Candida medium (CHROMagar, Paris, France) was prepared according to the 
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manufacturer’s instructions. The swab was inoculated into CHROMagar Candida medium 
rotating the swab head on the surface of the medium. The plates were incubated at 37C for 48 h. 
Colony morphology, and colour description were assigned in a standard manner by a single 
investigator. Presumptive species identification was performed according to Odds and Bernaerts 
[20]. At least one colony exhibiting each colour was streaked into a new CHROMagar Candida 
plate, and then cryopreserved. 
Molecular identification 
Yeast DNA was extracted using the QIAamp
®
 DNA Mini Kit (QIAGEN, Lisbon, Portugal) 
according to the manufacturer’s instructions. Genomic DNA content was determined by 
spectrophotometry readings at 260 nm. Aliquots of 10 l were analysed by electrophoresis in a 
0.8% agarose (Bio-Rad, Lisbon, Portugal) gel in 1 × TBE buffer (Bio-Rad, Lisbon, Portugal), 
and visualized with a UV transilluminator, after ethidium bromide (Bio-Rad, Lisbon, Portugal) 
staining (0.5 mg/ml). 
To assess the Candida speciation, a polymerase chain reaction method (PCR) previously 
described [14] was followed. This method uses primer mixtures of the Candida DNA 
topoisomerase II genes (Table 1). In a multiplex PCR strategy it allows the identification of C. 
albicans, C. guilliermondii, and C. parapsilosis using primer set A (Table 1) and C. dubliniensis, 
C. krusei, C. kefyr, and C. glabrata using primer set B (Table 1). C. tropicalis is identified in a 
third PCR reaction using a single pair of primers (Table 1). 
PCR amplification was performed in 25 µl volume consisting of: 1 × PCR buffer (160 mM 
(NH4)2SO4, 670 mM Tris-HCl pH 8.8, 0.1% Tween 20, and 25 mM MgCl2) (Bioron, Porto, 
Portugal); dNTP mixture (200 µM each) (Bioron, Porto, Portugal); primer mixture (300 nM 
each); 1.25 U Taq DNA polymerase (Bioron, Porto, Portugal); 10–100 ng genomic DNA 
template; the remaining volume consisted of sterilized ultrapure water. PCR was carried out in a 
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MyCycler thermal cycler (Bio-Rad, Lisbon, Portugal) under the following cycling conditions: 35 
cycles of 30 s at 94C, 15 s at 57C, and 45 s at 65C, after a 10-min initial period of DNA 
denaturation, and enzyme activation at 94C. One blank reaction was performed simultaneously 
per every 10 tests run by replacing the template DNA by sterilized ultrapure water. DNA from 
type strains was also included in each reaction as positive and negative controls.  
An aliquot of 15 µl of each PCR product was analysed by electrophoresis in a 1.2% agarose gel 
in 1 × TBE buffer. Fragments were visualized by ethidium bromide staining (0.5 mg/ml) with a 
UV transilluminator. The size of the amplified DNA fragments was determined by comparison 
with a 100-bp DNA marker (Bioron, Porto, Portugal). 
All the isolates whose presumptive identification in CHROMagar Candida did not correspond to 
the molecular identification were re-tested by two independent researchers in a blind assay. 
Statistical analysis 
CHROMagar Candida medium sensitivity was calculated as: [# true positives × 100 / (# true 
positives + # false negatives)], and specificity as: [# true negatives × 100 / (# true negatives + # 
false positives)]. Statistical analysis was performed using GraphPad Prism, version 5.00 software 
for Windows. Data was analysed using two-tailed chi-square test or Fischer test to measure 
association between Candida species distribution within groups. A statistical confidence interval 
of 95% was established.  
 
RESULTS 
Candida species identification 
Presumptive identification of yeasts clinical isolates was based on their colour on CHROMagar 
Candida medium. Samples were processed in parallel with C. albicans, C. krusei, and C. 
tropicalis type strains that presented the expected colours on CHROMagar Candida medium: 
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green, pink, and blue, respectively.  
For each culture, representative isolates were identified by PCR using Candida specific primers 
pairs for the genomic sequences of DNA topoisomerase II gene (Table 1) [14]. Reference strains 
DNA was included in each assay as control. DNA of C. albicans (Fig. 1A, lane 1), C. 
guilliermondii (Fig. 1A, lane 3), and C. parapsilosis (Fig. 1A, lane 4) were amplified using 
primer set A (Table 1). Primer set B (Table 1) allowed the identification of C. glabrata (Fig. 1B, 
lane 2), C. dubliniensis, C. krusei, and C. kefyr reference strains (data not shown). Finally, the set 
of primers C (Table 1) allowed the identification of C. tropicalis reference strain (Fig. 1C, lane 
5). For all Candida species the amplicon size obtained (Fig. 1) was as expected (Table 1). 
Clinical isolates identification was based on the comparison of the size of the amplified DNA 
products (assessed by the DNA ladder), with the respective type strain PCR product. Fig. 1 
shows an example of the identification of an isolate of C. albicans (lane 6), C. glabrata (lane 7), 
C. guilliermondii (lane 8), C. parapsilosis (lane 9) and C. tropicalis (lane 10). 
CHROMagar Candida phenotypic characteristics of the Candida species identified by PCR are 
specified in Table 2. As expected, C. glabrata, and C. parapsilosis did not present a 
distinguishable colour in this medium. Using PCR as a standard method, and considering the 
CHROMagar Candida identifying colours claimed by the manufacturer, CHROMagar Candida 
sensitivity, and specificity for C. albicans were found to be 97.9%, and 83.3%, respectively. For 
C. tropicalis CHROMagar Candida sensitivity was 66.7%, and specificity 100%.  
 
Candida species carriage 
From the 97 patients evaluated, 53 were identified as oral Candida carriers: 81.1% were females 
(n=43), and 18.9% males (n=10) with ages ranging from 28 to 91 years old (mean=61, and 
median=62 years old). Prosthesis wearers accounted for 84.9% of the individuals (n=45).  
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C. albicans was identified in 79% of the samples being the predominant Candida species. 
Additionally, C. parapsilosis comprised 6.5% of the isolates, followed by C. glabrata (4.8%), C. 
tropicalis (3.2%), and C. guilliermondii (1.6%). Five percent of the CHROMagar Candida 
positive samples (Table 2) were not identified. The distribution of Candida isolates within 
gender, and age groups is presented in Table 3. There was no association between C. albicans, 
and NCAC species carriage within (i) gender (P=0.7), (ii) the age groups defined (P=0.83) or 
(iii) prosthesis wearing (P=1). 
Seventeen percent of the individuals (n=9) presented more than one Candida species per sample 
(Table 4). These individuals (seven females, two males) had a mean age of 58 years old 
(range=38-88 years old). The percentage of patients wearing prostheses in this sub-population 
(88.9%) was similar to the observed in the population studied. 
 
DISCUSSION 
Motivation for microbiological tests in the field of oral medicine includes diagnosis, choice of 
therapy, treatment control, and risk evaluation [6]. This study focused on diagnostic, and risk 
evaluation.  
The diagnosis approach used herein included a primary isolation on a chromogenic medium 
(CHROMagar Candida) followed by Candida species identification using a previously described 
PCR method [14]. The CHROMagar Candida phenotypic characteristics of the Candida species 
identified by PCR are specified in Table 2. In comparison with PCR, there was a lower 
sensitivity, and specificity of CHROMagar Candida in the identification of C. tropicalis, and of 
sensitivity regarding C. albicans, also described by other authors [27]. In fact, the low sensitivity 
shown by C. tropicalis to CHROMagar Candida (66.7%) is due to the fact that one isolate 
further identified as C. tropicalis presented green colour (Table 2), instead of the characteristic 
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blue one. C. tropicalis isolates developing dark pink [28], lavender [19,27], and white colour 
[27] on CHROMagar Candida have also been reported. Regarding C. albicans, two isolates that 
developed green colour on CHROMagar Candida were not identified as C. albicans (Table 1). In 
addition, one of the isolates, further identified as C. albicans, developed pink colour in 
CHROMagar Candida. In accordance, some literature reports show that C. albicans isolates can 
develop atypical colours in CHROMagar Candida which include pink [25], white [27], blue or 
lavender [19]. It should be noted that in the same plates containing these atypical strains, isolates 
of C. albicans, and C. tropicalis with the expected colour phenotype were identified. 
Additionally, three yeast isolates were not identified by the PCR method using specific primers 
for the most common species (Table 2). A comparison between literature reporting yeast species 
frequently isolated from the oral cavity [18], and colours developed by Candida species in 
CHROMagar Candida [20], suggests that the unidentified isolate developing green colour might 
be a Trichosporon species, and the pink isolates might be: C. famata, C. inconspicua, C. 
lusitaniae, C. norvegensis, C. pelliculosa or S. cerevisiae. 
Results presented herein evidence that CHROMagar Candida medium failed to identify some 
yeast isolates, and that species identification should be supported by other methods, such as the 
molecular ones. Nevertheless, this medium facilitates the recognition of polymicrobial species in 
cultures, as exemplified in Table 4.  
The analysis of the epidemiological literature on the recovery of Candida species from the oral 
cavity is not clear concerning factors determining colonization. The reasons of such variability 
may include different patient selection criteria, collection data period, geographic region in 
which the patients live, sampling collection methods, and methodology used for sample analysis. 
In the present study, the prevalence of yeasts isolated was 54.6%, and between 41% to 67% in 
previous studies [2,7,9,17,29]. However, due to the irregular distribution of Candida in the oral 
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cavity [26], it cannot be discarded that swab samples can yield false-negative results, and thus a 
misclassification of true carriers as non–carriers. The Candida carriage frequency observed 
herein was: C. albicans > C. parapsilosis > C. glabrata > C. tropicalis > C. guilliermondii 
(Table 3), with NCAC species standing for 21% of the total Candida species. The increased 
prevalence of C. parapsilosis within NCAC species was also observed in Portuguese patients 
with fungaemia [5], suggesting that C. parapsilosis might be an important fungal pathogen in 
Portugal. Nevertheless prevalence of C. tropicalis [9], C. parapsilosis [11], C. famata [15] or C. 
glabrata [17,29] over other NCAC species in the oral cavity has been shown, and such variation 
may be due to patient age or underlying disease. 
The distribution of Candida isolates within gender, and age groups are presented in Table 3. In 
the current study there was no association between C. albicans versus NCAC species carriage 
within gender or age, likewise the observed by other authors [13]. Nevertheless, NCAC species 
recovered from samples of patients with more than 80 years old were exclusively C. 
parapsilosis, and C. glabrata (Table 3), suggesting an association between this age group, and 
these Candida species. Even so, as only two NCAC species have been isolated in this age group, 
an increase in sample size would be necessary to establish a conclusive association. 
Earlier studies scarcely report the identification of mixed Candida cultures. However, in recent 
years, researchers became aware of it, and the refinement of identification procedures allowed 
the discrimination of multi-Candida species in culture. As observed in other studies 
[2,8,16,17,24,29], the most common association found herein was C. albicans plus C. glabrata 
(Table 4). Nevertheless, the epidemiological data available report the association between other 
Candida species [2,8,15-17,24,29]. It is interesting to note that in the current study C. 
parapsilosis was the only NCAC species identified that was not exclusively co–isolated with 
other Candida species (Table 3, and 4). In fact, other authors have reported that the colonization 
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with NCAC species, as the sole species, is lower when compared with its co–colonization with 
other species [17]. This suggests that multi–species colonization may support the maintenance of 
the oral NCAC population contributing to increased interactions with molecules, and surfaces in 
the oral cavity. In fact, it was shown that the intensity of colonization by more than one Candida 
species was higher than the observed with single species [17]. However, when host natural 
defences decay, the benign colonization can develop into oral candidiasis, and antifungal therapy 
may support NCAC species emergence as the sole detectable species from oral lesions. In fact, 
results from the ARTEMIS DISK Global Antifungal Surveillance Program [21-23] show that 
Candida species resistance to fluconazole can be ranked as follow: C. glabrata, 16%, C. 
guilliermondii, 13%, C. tropicalis, 2.6%, C. parapsilosis, 2.4%, and C. albicans, 1.2%. These 
findings suggest that multi–species carriers might be at higher risk, than the mono–species 
carriers, of developing oral candidiasis, and of being resistant to antifungal therapy. 
According to the World Medical Association Declaration of Helsinki, purposes of research 
involving human individuals might be the advance in prophylactic, diagnostic, and therapeutic 
procedures as well as a better understanding of the aetiology of the disease. The present study 
fulfilled some of these issues. The diagnosis of oral Candida carriage before the presentation of 
clinical symptoms allowed the possibility of (i) dental hygiene education for routine oral care, 
(ii) control of the spread of the colonization through the monitoring of colonization, and (iii) use 
of therapeutic approaches when appropriated. Finally, the main observation that may contribute 
to a better understanding of Candida oral carriage arose from the high frequency of 
polymicrobial cultures, which may represent an increased risk of infection to patients, requiring 
careful surveillance. 
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Figure 1 Candida species-specific amplification of DNA topoisomerase II fragments. Genomic 
DNA was amplified using different sets of species-specific primers (from A to C), in accordance 
to Table 1. Lanes: M, 100-bp DNA marker with their molecular size in bp is indicated in the left 
margin; 1- C. albicans CECT 1472; 2- C. glabrata ATCC 2001; 3- C. guilliermondii ATCC 
6260; 4- C. parapsilosis ATCC 22019; 5- C. tropicalis ATCC 750; 6–10- example of clinical 
isolates of each species; 11- blank. C. dubliniensis, C. krusei ATCC6258, and C. kefyr ATCC 
204093 identification was omitted for simplicity. Arrows on the right indicate the molecular 
weight of the amplified products.  
Manuscrito legend to figure
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Table 1 Primers sets and species specific primers used in this study (as described by Kanbe et al. [14]) 1 
Primers 
sets 
Target species Forward primer sequence (name) Reverse primer sequence (name) Expected PCR 
product size (bp) 
A
a
 C. albicans 5’-TTGAACATCTCCAGTTTCAAAGGT-3’ 
(CABF59) 
5’-AGCTAAATTCATAGCAGAAAGC-3’ 
(CADBR125) 
665 
 C. 
guilliermondii 
5’-CCCAAAATCACAAAGCTCAAGT-3’ 
(CGLF41) 
5’-TACGACTTGAAGTTGCGAATTG-3’ 
(CGLR61) 
205 
 C. parapsilosis 5’-GGACAACATGACAAAAGTCGGCA-3’ 
(CPPIIF41) 
5’-TTGTGGTGTAATTCTTGGGAG-3’ 
(CPPIIR69) 
310 
B
b
 C. dubliniensis 5’-AAATGGGTTTGGTGCCAAATTA-3’ 
(CDBF28) 
5’-GTTGGCATTGGCAATAGCTCTA-3’ 
(CDBR110) 
816 
 C. krusei 5’-GAGCCACGGTAAAGAATACACA-3’ 
(CKSF35) 
5’-TTTAAAGTGACCCGGATACC-3’ 
(CKSR57) 
227 
 C. kefyr 5’-CTTCCAAAGGTCAGAAGTATGTCC-
3’ (CKFF35) 
5’-CTTCAAACGGTCTGAAACCT-3’ 
(CKFR85) 
532 
 C. glabrata 5’-CCCAAAAATGGCCGTAAGTATG-3’ 
(CGBF35) 
5’-ATAGTCGCTACTAATATCACACC-3’ 
(CGBR103) 
674 
C
c
 C. tropicalis 5’-CTGGGAAATTATATAAGCAAGTT-3’ 
(CTPIIF36) 
5’-TCAATGTACAATTATGACCGAGTT-
3’ (CTPIIR121) 
860 
In the original report [14] primers sets had the designation of 
a
PsI, 
b
PsII, and 
c
PsIII  2 
Table 1
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Table 2 Colour of colonies on CHROMagar Candida medium for species identified by PCR  
Species  # Colony colour 
 Green Blue Pink 
C. albicans  48 - 1 
C. parapsilosis - - 4 
C. glabrata  - - 3 
C. tropicalis 1 2 - 
C. guilliermondii - - 1 
Unidentified 1 - 2 
 
Table 2
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Table 3 Frequency of distribution of Candida species isolated and patients’ characteristics 
Patients 
characteris
tics 
Species
a
 frequency, % (#) 
C. 
albicans 
NCAC species 
C. 
parapsilosis 
C. 
glabrata 
C. 
tropicalis 
C. 
guilliermondi
i 
Unidentified 
Gender       
Female 80 (40) 6 (3) 4 (2) 4 (2) 0 (0) 6 (3) 
Male 75 (9) 8.3 (1) 8.3 (1) 0 (0) 8.3 (1) 0 (0) 
Age (years)       
≤ 54 82.6 (19) 4.3 (1) 4.3 (1) 4.3 (1) 0 (0) 4.3 (1) 
55-79 75.9 (22) 6.9 (2) 3.4 (1) 3.4 (1) 3.4 (1) 6.9 (2) 
≥ 80 80 (8) 10 (1) 10 (1) 0 (0) 0 (0) 0 (0) 
a
, PCR identification  
Table 3
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Table 4 Number of patients with more than one Candida species  
Species
a
 #patients 
C. albicans–C. glabrata 3 
C. albicans–C. tropicalis 2 
C. albicans–C. parapsilosis 1 
C. albicans–unidentified 2 
C. parapsilosis–C. guilliermondii 1 
a
, PCR identification 
Table 4
Figure 1
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